Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tocotrienols for Postmenopausal Women With Low Muscle Strength
NCT03708354Phase 2Withdrawn
- Sponsor
- Texas Tech University Health Sciences Center
- Start
- Apr 2019
- Primary completion
- Dec 2022
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial (2 arms), sponsored by Texas Tech University Health Sciences Center. Primary endpoint: lower-body muscle endurance at 24 weeks. Planned start Apr 2019; status: withdrawn.
Beyond the preview
Go deeper on NCT03708354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03708354.